A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.
Actinic Keratosis
DRUG: PEP005 (ingenol mebutate) Gel
To determine the photoallergic (sensitizing) potential of PEP005 Gel and it's vehicle on normal skin., 6 weeks
This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.